Solvay unit bid war looms after Abbott report

AMSTERDAM (Reuters) – A feared low price for Solvay’s drugs unit looked premature as a bidding war was seen to emerge after a report Abbott had bid up to 5 billion euros to rival a lower offer from Nycomed .

Leave a Reply